Irinotecan plus fluorouracil‐based regimen as second or third‐line chemotherapy for recurrent or metastatic esophageal squamous cell carcinoma

BACKGROUND: No standard second‐line regimen exists for the treatment of advanced esophageal squamous cell carcinoma (ESCC). The aim of this study was to evaluate the efficacy and safety of irinotecan and fluorouracil‐based chemotherapy as a second or third‐line regimen for advanced ESCC patients. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xi, Wang, Xinwei, Huang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773301/
https://www.ncbi.nlm.nih.gov/pubmed/27042229
http://dx.doi.org/10.1111/1759-7714.12323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773301/
https://www.ncbi.nlm.nih.gov/pubmed/27042229
http://dx.doi.org/10.1111/1759-7714.12323

Ejemplares similares